Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activityLing Li, Zichao Yang, Jingxuan Chen et al.|Bioorganic Chemistry|2021Cited by 40
Discovery of novel 2-aryl-4-bis-amide imidazoles (ABAI) as anti-inflammatory agents for the treatment of inflammatory bowel diseases (IBD)Ling Li, Chenglong Xu, Sijie Yuan et al.|Bioorganic Chemistry|2022Cited by 12
Corrigendum to “Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity” [Bioorgan. Chem. 117 (2021) 105447]Ling Li, Chenglong Xu, Yinrong Wu et al.|Bioorganic Chemistry|2024Cited by 0